Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 9.10
-0.34 (-3.60%)
Oct 2, 2026, 5:35 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €455.22 million as of October 2, 2026. Its market cap has increased by 170.95% in one year.
Market Cap
455.22M
Enterprise Value
520.68M
Revenue
60.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
€9.10
ChartMarket Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 455.22M, an increase of 211.65%. That is a compound annual growth rate of 5.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 455.22M | 73.63% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.40B |
| MedinCell | 865.47M |
| Inventiva | 778.54M |
| DBV Technologies | 613.73M |
| Valneva SE | 513.94M |
| Valerio Therapeutics Société anonyme | 265.21M |
| Transgene | 197.74M |
| Innate Pharma | 131.37M |